Introduction Despite a marked recent increase in the number of publications describing the incidence of venous thromboembolism (VTE) in Asia, and especially in mainland China, Hong Kong, Taiwan, Korea, Japan and Singapore, there remains a lack of consensus on the true risks, and trends over time, to inform appropriate clinical practice. The purpose of this systematic review was therefore to examine evidence about the incidence of symptomatic VTE in Asia. Methods Databases were searched for studies from Asia, published between January 1995 and February 2016, on the incidence of symptomatic VTE, deep vein thrombosis (DVT) or pulmonary embolism. Review of eligible studies was conducted independently by two reviewers. Data were extracted on incidence, predispositions and recurrence of VTE. Results One thousand nighty-five studies were identified, of which 73 were eligible for full text review and data extraction. Three population-wide estimates of VTE rates identified from Korea, Taiwan and Hong Kong reported annual incidences of 13.8, 15.9 and 19.9 per 100,000, respectively. Nine studies of Asian hospital registries or databases reported VTE rates ranging from 11 to 88 cases per 10,000 admissions. Population-based estimates of post-surgical DVT rates ranged from 0.15 to 1.35%. Age was a significant risk factor for VTE in all population groups. Conclusion Population-wide incidence estimates in Asia were approximately 15 to 20% of the levels recorded in western countries but have increased over time. It is anticipated this synthesis of evidence on the incidence of VTE and its predisposing factors will increase awareness about VTE in Asian populations.
Introduction
Until recently, there has been a relative lack of research into the incidence of venous thromboembolism (VTE) in Asian populations, 1 perhaps partly due to early impressions that VTE was rare in Asia. 2 However, the past 15 years have seen a marked increase in the number of publications, especially from mainland China, Hong Kong, Taiwan, Korea, Japan and Singapore. Most of these studies have reported significant VTE rates in the respective Asian populations, although reported rates were generally lower than those in western populations where VTE has an estimated annual incidence of 1 per 1,000 per annum, which makes VTE a major health issue. Although VTE is ranked the third most frequent cause of cardiovascular death in Western countries, 3 there remains a lack of acknowledgement of this condition in Asian populations. This systematic review aims to encapsulate the latest findings from Asia and raise awareness of VTE as an important condition in this region.
The effective management of symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE) requires early confirmation of clinically suspected disease. In turn, early confirmation is reliant on both clinicians and the public having a high local awareness of these disorders. A recent global survey indicated that clinical awareness regarding VTE is generally low in Asian countries. 4 Since the nations that comprise Asia account for more than half the world's population, such low local awareness about VTE is likely to add considerably to the avoidable burden from this disease.
The purpose of this systematic review is to examine evidence about the incidence of symptomatic VTE, reported between January 1995 and February 2016, in publications from East Asia. The focus is on population-based and other studies of VTE incidence, temporal trends in reported VTE rates, and the contributions of age and other major predisposing conditions. The results may help increase awareness about the importance of VTE in Asian populations.
Existing Asian VTE guidelines are summarized in ►Table 1. The present synthesis of evidence on the incidence of VTE and predisposing factors may inform future refinements and updates of VTE-related guidelines in Asia.
Methods
For the purposes of this study only symptomatic VTE was considered and Asian populations were defined as people from the geographical regions of East Asia including China (including Hong Kong and Macau), Taiwan, Mongolia, Korea (North and South) and Japan, Southeast Asia including Vietnam, Malaysia, Thailand, Indonesia, Singapore and Table 1 List of Asian guidelines and expert recommendations on prevention and/or management of venous thromboembolism (VTE) Philippines, and South Asia including India, Pakistan, Afghanistan, Bangladesh and Sri Lanka.
A systematic search of the literature using the PICOT (Population, Intervention, Comparison, Outcome, Type) approach 5 and the PRISMA checklist 6 was conducted to identify English-language publications. The predetermined inclusion criteria were the following: (1) the population studied included at least 90% Asian participants or the study was conducted in one of the specified Asian countries; (2) the full publication was available in English; (3) the reported study included at least 100 subjects from the Asian population of interest; (4) the publication reported the disease burden and/or risk and demographic factors associated with symptomatic VTE; (5) the publication date was from 1995 to 2016.
Data Collection and Analysis

Selection of Studies
A wide, all-encompassing search string was developed through an iterative process and the final literature search was conducted in PubMed (MEDLINE) on 23 February 2016 (see Appendix A for search string). Two reviewers independently screened the title and abstract for each manuscript against the predefined inclusion and exclusion criteria (see ►Fig. 1). Full-text manuscripts were obtained for all abstracts that were deemed potentially eligible by at least one reviewer. Two reviewers then independently screened the full-text articles for eligibility using a standardised data extraction form. Any discrepancies were resolved by discussion and/or consultation with a third reviewer (n ¼ 42).
Searching Other Resources
The reference lists of all papers included were hand searched to identify any additional manuscripts that may have been omitted in the initial search; the 'related article' feature in PubMed was also used to identify additional articles. Google Scholar, EMBASE and the grey literature were also searched to cross-check for additional relevant articles (see ►Fig. 1).
Grouping of Studies
Included studies were grouped, according to the study protocol, as belonging to one of the following categories: (1) populationbased studies, defined as population-based estimates of VTE incidence or mortality in the general population, from sources such as national health system registries or health insurance databases; (2) hospital evidence, defined as single institution or multicentre estimates of VTE incidence or mortality in the general population, or reports of VTE rates in consecutive hospitalized patients, surgical patients or general oncology patients; (3) autopsy evidence, defined as studies of PE incidence in series of autopsy records or death certificates; (4) special interest studies based on large population or patient groups; (5) studies of VTE in subpopulations or patient cohorts. Only high-quality studies with a low risk of bias were reported.
For population-based studies, ICD-9 or ICD-10-CM classifications were used. This system is the ninth or tenth revision of the World Health Organization International Statistical Classification of Diseases and Related Health Problems (ICD) clinical modification (CM).
Results
The search strategy identified a total of 1,095 manuscripts. Initial title and abstract searches identified 227 potentially relevant studies. Hand searching of reference lists and additional searches identified a further 25 potentially relevant studies. Detailed abstract and/or full-text review identified 95 potentially relevant studies that met the criteria for data extraction. The following full-text review publications were excluded for the following reasons: small sample size (Supplementary references, 1-3); letter to the editor or literature review without new data (S4-S6); lack of denominator value, therefore no incidence reported or calculable (S7-S9); survey-based studies with poor response rates (S10-S13); duplicated data (S14); only non-symptomatic/sub-clinical disease, for example, VTE diagnosed by systematic screening with venous ultrasound imaging, or after D-dimer assay; incidence estimate extrapolated from less than 90% of the population of interest (S15); the report concerned predisposition for PE in people with a DVT(S16); or VTE was not a main study outcome of interest (S17). A total of 73 manuscripts met the eligibility criteria for data extraction (►Fig. 1). These were from Taiwan, Hong Kong, Singapore, China, Korea, Malaysia, Philippines, Thailand, Japan and India.
Population-Based Estimates of Incidence
Population-Wide Annual Incidences of VTE
Population-wide estimates derived from international classification of disease-coded population health data sets (ICD-9 or ICD-10-CM) were identified from Korea, 7 Taiwan 8 and Hong Kong 9 (►Table 2).
The Korean study utilized a data set containing all inpatient and outpatient encounters recorded from 2004 to 2008 and investigated DVT alone and PE, with or without DVT. 7 The Taiwanese study utilized data from the National Health Insurance programme, covering 99% of the population and 97% of hospitals and clinics, and recorded VTE rates from 2001 to 2002 in people older than 18 years. 8 The Hong Kong study was derived from public hospital admission and discharge statistics in 2000 and 2001, covering 95% of the population. 9 In Korea, the age-and sex-adjusted annual VTE rates per 100,000 were 8.83 in 2004 and 13.8 in 2008. In Taiwan, the crude incidence of VTE was 15.9 per 100,000 person-years; in Hong Kong, the crude rates were 17.1 per 100,000 for DVT, 3.9 for PE and 19.9 for VTE (►Table 2).
A Japanese study reported death certificate data in which death was attributed to PE, as recorded in 'Vital Statistics of Japan' from 1951 to 2000, and data were adjusted to the population size in 1985. The reported rate of 'fatal PE' increased from 0.08 per 100,000 in 1956 to 0.77 per 100,000 in 1996. 10 all derived from the Taiwan National Health Insurance databases. Each study reported absolute DVT, PE or VTE rates in cases and matched controls, together with adjusted incidence hazard ratios (HR; ►Table 3).
Medical Disorders, Injuries and Toxicities
The estimated incidence of PE was significantly higher in patients with chronic inflammatory disorders than in ageand sex-matched controls. The disorders included systemic lupus erythematosus (SLE; PE rate of 10.2 per 10,000 patientyears; HR: 19.7; 95% confidence interval [CI]: 11.9; 32.8), 11 systemic sclerosis (SSc) (10.8 per 10,000 patient-years), 12 chronic obstructive pulmonary disease (COPD; 12.31 per 10,000 patient-years) 13 and asthma (10.2 per 10,000 patientyears). 14 Estimated incidence rates of DVTwere also significantly higher in patients with COPD, 13,15 SLE, 11 Sjogren's syndrome (SS), 16 SSc, 12 . Two studies only recorded VTE incidence, and both showed significantly higher rates in patients with dermatomyositis (HR: 11.1; 95% CI: 5.2, 23.6) and liver cirrhosis (HR: 7.7; 95% CI: 5.2, 11.4) 23 compared with controls. Other conditions with higher estimated incidence rates of DVT or VTE, compared with controls, included spinal cord injury, 24 organophosphate toxicity, 25 carbon monoxide poisoning, 26 schizophrenia, 27 sleep disorders, 28 hormone replacement therapy 29 and type 2 diabetes mellitus. 30 Metformin use in type 2 diabetes was associated with a reduced risk of DVT with 0.22% of cases compared with 0.56% of controls affected (HR: 0.43; 95% CI: 0.24, 0.56; 31 ►Table 3).
Post-surgical VTE Rates
Seven population-based studies reported the rates of VTE recorded within 4 to 5 weeks, or within 3 months, of surgery [32] [33] [34] [35] [36] [37] [38] (►Table 4). Five studies were of patients who had major joint surgery (Taiwan n ¼ 3; Korea n ¼ 2), another (Korea) examined VTE rates after major surgery (including joint surgery) and a study from Japan investigated rates after spinal surgery. The estimated incidences of symptomatic VTE following total hip arthroplasty (THA) were 0.15, 37 0.27, 32 0.40, 34 0.98 36 and 1.35% 39 in five separate studies. After total knee arthroplasty (TKA), the reported incidence ranged from 0.22 to 1.2%. Hip fracture surgery (1.60%) and cancer surgery (0.67%) were associated with high VTE incidence rates in Korea 36 (►Table 4).
Pregnancy-Related VTE Rates
Only one large-scale population study investigating pregnancyrelated VTE rates was identified, and reported the annual rate increased from 2006 to 2010 in South Korea (the overall incidence was 0.82 per 10,000 deliveries during the 5-year period). 40 
VTE as a Hospital Discharge Diagnosis
Prevalence of VTE among All Hospital Inpatients
Nine studies 9,41-48 reported the number of patients with a discharge diagnosis of DVT, PE or VTE per 10,000 hospital inpatients, as recorded in hospital or registry databases in mainland China, Hong Kong, India, Japan, Korea and Singapore. These ranged widely from 11 to 65 per 10,000 for DVT, 2.5 to 23 per 10,000 for PE and 11 to 88 per 10,000 for VTE. In Singapore, the prevalence of DVT among inpatients increased from 16 cases per 10,000 admissions in 1996/1997 to 65 cases per 10,000 admissions in 2006 (►Table 5).
Prevalence of VTE in Medical Inpatients
Three studies of symptomatic VTE among medical or 'high-risk' medical inpatients in Thailand and Singapore 49 and one study of VTE after an ischaemic or haemorrhagic stroke in Taiwan are shown in ►Table 6. The reported VTE prevalence was 0.2 to 0.9% of inpatients (1.6% in patients with chronic liver disease).
Prevalence of VTE among Surgical Inpatients
The rates of symptomatic post-surgical VTE in 10 single hospital studies or multicentre registries from East Asia, This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. 
Old Age, Gender and Other Potentially Contributing Conditions
Old Age
Four population-based studies (►Table 2) describe strong associations of VTE risk with advancing age. In Korea, relative to the 30-to 39-year age group, there was a sixfold increase in risk by age 60 to 69 years, and a 15-fold increase by age greater than 80 years when the absolute annual rate was just over 1/1,000 people. 7 The absolute annual VTE rate of 0.02 per 1,000 women and 0.03 per 1,000 men aged less than 30 years, increased to 1.2 and 0.8 per 1,000 among women and men aged greater than 80 years. 8 Observations were similar in Hong Kong and Japan. 9,10
Gender
Three population-wide studies reported on gender and VTE risks. In one study, women were less likely to have a diagnosis of VTE (relative risk [RR]: 0.96) or DVT alone (RR: 0.87) but more likely to have a diagnosis of PE (RR: 1.11). 7 In a second study, 54% of patients with VTE were female, 8 while the third study reported no significant difference. 9 Women slightly outnumbered men in seven of nine hospital or registry-based cohorts of patients with VTE (a tendency most pronounced in two of the three studies from Japan; ►Table 7). 44, 50 Other Comorbidities and Potential Predispositions
In Taiwan, a population-based analysis of VTE rates and associated risk factors, or predispositions, showed that 16% of cases had previous VTE, and most VTE was associated with predisposing conditions (22% malignancy, 17% serious neurological disease, 8% major trauma 8% and 38% major surgery during the preceding 3 months), although 27% had no recorded predisposition. 8 54 Patients with a gynaecological malignancy had VTE rates of 3.3% during 5 years of follow-up in a population-based study from Taiwan, 55 and 1.3% in a hospital cohort from Thailand (where most VTE was associated with ovarian cancer). 56 The 2-year incidence of VTE was 4.9% after inoperable gastric cancer (metastatic or recurrent) in a cohort from Korea. 57 VTE rates were 1.4% during 4 months after starting thalidomide for relapsed or refractory multiple myeloma in Japan, 58 and less than 1% in Korean patients with acute myeloid leukaemia. 59
Other Observations: Recurrence Rates and Case Fatality Rates
A population-wide study of over 5,000 Taiwanese adults discharged from hospital after an admission with VTE in 2001 or 2002 found that annual crude recurrence rates were 5.1% in men and 5.2% in women, during up to 4 years (average 2.26 years) of follow-up. 8 A recurrence was most likely during the first 12 months after VTE (with cumulative rates of 4.6, 6.7 and 9.4%, after 3, 6 and 12 months, respectively, which reached 14.4% at 4 years), and was three to four times more likely in patients with a previous VTE or cancer than if the predisposition was transient or the index VTE was apparently unprovoked. 8 This and another population-based report found high case fatality rates. In Taiwan, 4.3% of patients with VTE died in hospital, 7.5% died within 1 month and 14.9% died within 6 months; mortality was higher after PE than DVT. 8 In Hong Kong, 7.3% of admissions with a DVT and 23.8% of those with PE died in hospital, and VTE-associated mortality was greatest in the elderly. 9 High 30-day or in-hospital mortalities were also reported in a questionnaire-based survey from Japan (7% after DVT, 13% after PE), 60 a PE registry from China (9% in 2008) 41 and hospital cohorts in Singapore (12%) 47 and India (13%). 43 
Temporal Trends
The reported incidence of VTE has increased during recent decades, in population-wide studies from Korea and Japan (see above) in registries, and in hospital databases. There was an almost fivefold increase in the annual number of patients recorded between 1997 and 2008 in a very large Chinese PE registry, 41 and a fivefold rise in admissions with acute DVT at a Singaporean hospital between 1990 and 1997. 46, 47 In China, the start of a nationwide project to improve diagnosis and management of VTE coincided with a sharp upturn in the number of patients registered as having PE. 41 
Discussion
This systematic literature review of evidence regarding the population-based incidence of symptomatic VTE in East Asian populations confirms the frequency and importance of this 
VTE Incidence in Asia Compared with the West
Recently published population-wide estimates of annual symptomatic VTE rates in Korea, Taiwan and Hong Kong are approximately 15 to 20% of the level recorded in Western countries ($100 per 100,000 people). 61 However, the reported annual incidence in East Asian populations increases to approximately 1 per 1,000 people aged !80 years, 7-9 as compared with 3 per 1,000 in some Caucasian populations. 57 In addition, the National Health Insurance data from Korea, Japanese vital statistics of deaths attributed to PE, data from PE registries and hospital admission statistics all indicate a rise in reported VTE rates over time across East Asia. 7, 8, 46 Hospital data from large registries and databases corroborate the findings in population-health studies and potentially provide more accurate and robust estimates of VTE rates in certain patient groups (►Table 5). Across nine studies, the prevalence of VTE and the increasing temporal trend across three studies from Singapore echoed that of population-based studies. Rates of symptomatic, post-operative VTE (►Table 6) are difficult to compare with Western values due to differing methodologies. In a South Korean population-based study, 40 the incidence of pregnancy-related VTE was 0.82 per 10,000 deliveries, much lower than the Western rates of between 10 and 20 per 10,000 deliveries.
Accuracy of Population-Based Datasets
Estimates of population-wide VTE rates, based on populationwide databases, not only require these to include both inpatient and outpatient encounters, but also rely on accurate reporting using International Classification of Diseases (ICD) or local disease classification, evidence of anticoagulant therapy and the assumption that every patient at discharge or at censure had confirmatory tests or a post-mortem to identify VTE. Therefore, any attempt to estimate population-wide VTE rates has limitations and inherent biases. There is a risk of under-reporting, because VTE must be identified in the medical record to ensure a correct discharge diagnosis, and clinically significant PE or DVT is often misdiagnosed or unrecognized. 62 It is also important to note that the algorithms used to define DVT, VTE and PE based on ICD-9 or ICD-10 codes can vary from study to study and result in inaccurate estimation. For example, in some studies, the category DVT also included inferior vena cava (IVC) thrombosis, renal vein thrombosis and/or thrombophlebitis. [7] [8] [9] A systematic review of studies done to validate the identification of VTE using administrative and claims data showed that reliability varies considerably and positive predictive values (PPVs) are highest when multiple codes are combined. 63 The range of PPVs reported using combined ICD-9 codes for DVT, PE or VTE was 65 to 95%. Ng et al 23 also validated their Taiwanese database by medical chart review of a random sample and found a PPV of 94.0% for VTE.
The strengths of population-based data include large sample size and ability to capture the entire population.
Risk Factors and Recurrence
It is of interest that the comorbidities and likely predispositions for VTE are similar in East Asia and in the West, most notably old age, cancer, previous VTE, immobility, trauma and surgery, and inflammation. Of particular note are the population-based cohorts with case-control comparisons, from Taiwan, which show high HR for VTE in many acute or chronic autoimmune and other inflammatory disorders (e.g. systemic lupus, SS and rheumatoid arthritis) compared with controls. There is a noteworthy finding that DVT rates were less in type 2 diabetes patients prescribed metformin; 31 recent laboratory studies have shown that metformin inhibits platelet activation and release of mitochondrial DNA (deoxyribonucleic acid). 64 Apart from the South Korean population study in pregnancy-related VTE, 40 it is important to acknowledge the lack of published evidence from large VTE studies in Asian populations for the predispositions of pregnancy, the perinatal and post-partum period, and gynaecological laparoscopic surgery.
The overall recurrence rate of 10% during the first year after presenting with VTE, recorded in a population-based study from Taiwan, is similar to 1-year recurrence rates reported in the West of 5.6 to 12.9%. 65 Surprisingly, the risks of a recurrence after a transiently provoked or supposedly unprovoked VTE were similar ($5% during 1 year), which suggests that Western guidance on treatment duration should be validated in Asia.
Lower Asian Venous Thromboembolism Rates
There has been much speculation about why the reported VTE rates might be lower in Asia than the West. 61, 66 Explanations have included under-diagnosis, low clinician awareness and the near absence in Asia of thrombophilias commonly found in Caucasian populations, such as factor V Leiden and prothrombin gene mutations. Yet this review has confirmed a clear trend of increasing VTE rates over time, across multiple population-and hospital-based studies. It is likely that in part under-diagnosis and under-reporting in early studies, followed by improved diagnosis in later years with greater awareness and perception that VTE is an issue in Asian populations, have contributed to this trend. In Singapore 47 and Hong Kong, 67 it was shown that reported VTE rates have increased as Doppler ultrasound scans were used more often and the institutions established a lower threshold for performing diagnostic tests. Similarly, PE rates in China surged following a nationwide programme to improve awareness and management of this condition.
Nevertheless, it seems likely that there has also been a genuine increase in VTE prevalence in Asian populations, perhaps because of increasing population age, increasing cancer rates and an increasing number of surgeries. The rates reported in elderly people from Asian countries suggest that the gap between VTE rates in Asia and the West will diminish further still.
Improving Awareness of VTE in Asia
A recent survey found variable public awareness of VTE worldwide and very low awareness in Asia. 66 inadequate clinician awareness as well as low public awareness of VTE in Asia 61 is likely to result in a general trend towards under-diagnosis. This is exemplified by the Chinese PE registry, where a sharp upturn in the number of reported patients with PE coincided with a nationwide programme to improve awareness and management of this condition. 9 The increase in reported VTE rates over time recorded by several studies identified in this systematic review suggests initial under-diagnosis and rising diagnostic awareness. Most of the population-based studies reviewed here were based on data collected more than 10 years ago (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) , and the current VTE rates may be considerably higher.
Implications for Guidelines and Other Asian Countries
Our estimates of population burden from VTE in East Asia come from Hong Kong, Korea, Taiwan and (with less methodological confidence) Singapore. It is important to stress that these estimates should not be directly extrapolated to places with different health care systems and less extensive databases, so that similar statistics from other countries in the region such as India, Malaysia, the Philippines and Indonesia are much needed. Data on the population disease burden of VTE across Asia will also allow racial and ethnic differences in VTE to be better studied.
►Table 1 lists guidelines and expert recommendations from Asia about VTE risk assessment, prevention and management. Several of these include summaries of the literature on VTE rates and VTE prevention trials in Asia. Most base their recommendations for anticoagulant prophylaxis, explicitly or implicitly, on international guidelines derived from Western data for Western populations, where the balance of absolute benefit and absolute risk may not be the same as in Asia. This and other recent surveys of evidence 68 find an increasing incidence of VTE in Asian populations. This emphasizes the need to validate Western VTE management guidelines in populations from Asia.
Conclusion
Together, Asian countries account for more than half the world's population and their contribution to the global VTErelated burden of disease is considerable, albeit at lower levels than Western countries. This systematic review reinforces and extends conclusions from previous reviews that VTE rates in Asia are significant and rising, both community-wide and among medical and surgical inpatients. Although the published data have methodological limitations, the evidence is consistent and persuasive regarding the incidence and predispositions for VTE in East Asia.
There is a need for greater awareness of VTE and its diagnosis and management in old age, cancer, inflammatory disorders and after surgery. Advice on anticoagulant or other VTE prophylaxis after surgery in Asia requires more extensive studies of both incidence and potential bleeding risks. Without more local evidence, the local guidelines on VTE prevention and management, which are tailored to needs of the Asia-Pacific region, must rely heavily on North American or European guidance. Doubts about their local applicability may contribute to poor guideline adherence.
What is known on this topic?
• There tends to be a lack of awareness of venous thromboembolism (VTE) as a problem in Asian populations. • Although a large number of studies have investigated the incidence of VTE in Asia, there remains a lack of agreement regarding the true present risks of VTE in Asian populations.
What this paper adds?
• This systematic literature review brings together and summarizes published evidence on VTE from several Asian countries. 
